Hengrui Pharma (600276.SH): HRS-6209 capsules and two other drug candidates have been approved to commence clinical trials.

Hengrui Pharma (600276.SH) announced that the company and its subsidiaries, Shandong Shengdi Pharmaceutical Co., Ltd. and Guangdong Hengrui Pharmaceutical Co., Ltd., have recently received the "Notice of Approval for Drug Clinical Trials" from the National Medical Products Administration for HRS-6209 capsules, HRS-8080 tablets, and HRS-9813 capsules, and will initiate clinical trials shortly.

Zhitong FinanceJun 9 17:15

On June 9, Hengrui Pharma (01276) repurchased 70,000 A-shares at a cost of RMB 3.1936 million.

Hengrui Pharma (01276) announced that on June 9, 2026, the company repurchased 70,000 A-shares at a total cost of RMB 3.1936 million, with a per-share repurchase price ranging from RMB 45.30 to RMB 45.82.

Zhitong FinanceJun 9 16:49

June 8 Buyback Roundup | AIA, Tencent, and others announced share repurchases, with AIA spending HK$680 million.

According to a disclosure filed with the Hong Kong Exchange on June 9, AIA (01299.HK), Tencent (00700.HK), and others repurchased shares. ① AIA (01299.HK) repurchased 9.352 million ordinary shares on June 8, for a total consideration of HK$680 million, at prices ranging from HK$71.95 to HK$74 per share. Since the adoption of the share repurchase mandate, the company has cumulatively repurchased 72.1634 million securities, representing 0.6903% of the issued shares outstanding as of the date the ordinary resolution was passed. ② Tencent (00700.HK) on

Futu NewsJun 9 09:30

Zhitoong HK Connect Holding Ratio Anomaly Statistics | June 9

Zhitong HK Connect Holdings Ratio Anomaly Statistics | June 8, 2026

Zhitong FinanceJun 9 08:36

On June 8, Hengrui Pharma (01276) repurchased 444,000 A-shares at a cost of RMB 20.4257 million.

Hengrui Pharma (01276) announced that on June 8, 2026, the company repurchased 444,000 A-shares at a cost of RMB 20.4257 million.

Zhitong FinanceJun 8 16:21

June 5 Buyback Roundup | AIA, Tencent, and others announced share repurchases, with AIA spending HK$650 million.

According to a filing disclosed by the Hong Kong Exchange on June 8, AIA (01299.HK), Tencent (00700.HK), and others repurchased shares. ① AIA (01299.HK) repurchased 8.7458 million ordinary shares on June 5, for a total consideration of HK$650 million, at prices ranging between HK$76 and HK$73.55 per share. Since the repurchase mandate was approved, the company has cumulatively repurchased 62.8114 million securities, representing 0.6008% of the issued shares outstanding at the time the ordinary resolution was passed. ② Tencent (00700.HK)

Futu NewsJun 8 09:30